Renal oncocytoma screening: Difference between revisions
Jump to navigation
Jump to search
Homa Najafi (talk | contribs) No edit summary |
Homa Najafi (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}}{{Homa}} {{SC}} | {{CMG}}; {{AE}}{{Homa}} {{SC}} | ||
==Overview== | ==Overview== | ||
There is insufficient evidence to recommend routine [[Screening (medicine)|screening]] for renal oncocytoma. | |||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine [[screening]] for renal oncocytoma. | |||
==References== | ==References== | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 14:40, 6 May 2019
|
Renal oncocytoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Renal oncocytoma screening On the Web |
|
American Roentgen Ray Society Images of Renal oncocytoma screening |
|
Risk calculators and risk factors for Renal oncocytoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2] Shanshan Cen, M.D. [3]
Overview
There is insufficient evidence to recommend routine screening for renal oncocytoma.
Screening
There is insufficient evidence to recommend routine screening for renal oncocytoma.